David Hung, President & CEO, Director at Medivation, holds 13.19K shares in NovoCure (Ticker: NVCR), holds 58.28M shares in Nuvation Bio (Ticker: NUVB), holds 0.00 shares in Sio Gene Therapies (Ticker: SIOX).
David Hung latest transaction was an Uninformative Buy of ―.
What was David Hung's most profitable transaction?
David Hung’s most profitable transaction was an Informative Sell of MDVN stock on December 4, 2014. The return on the trade was 24.40%.
What is David Hung's role in Medivation?
David Hung's role in Medivation is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.